Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Janet Rader

Concepts (647)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Uterine Cervical Neoplasms
85
2025
299
12.700
Why?
Papillomavirus Infections
19
2025
173
2.900
Why?
Ovarian Neoplasms
37
2024
459
2.730
Why?
Endometrial Neoplasms
34
2019
144
2.360
Why?
Uterine Cervical Dysplasia
16
2017
51
2.340
Why?
Carcinoma, Squamous Cell
31
2018
332
1.970
Why?
Gene Expression Regulation, Neoplastic
19
2025
857
1.870
Why?
Human papillomavirus 16
8
2019
44
1.690
Why?
Papillomaviridae
17
2025
105
1.580
Why?
Female
191
2025
28171
1.530
Why?
Gene Expression Profiling
9
2021
1105
1.480
Why?
DNA Methylation
22
2025
592
1.300
Why?
Antineoplastic Combined Chemotherapy Protocols
17
2013
1031
1.260
Why?
Genital Neoplasms, Female
10
2018
48
1.160
Why?
Human papillomavirus 18
5
2019
9
1.150
Why?
Humans
194
2025
52483
1.130
Why?
Genetic Predisposition to Disease
14
2024
528
1.090
Why?
Adult
92
2024
14161
1.050
Why?
Neoplasm Staging
41
2019
772
1.010
Why?
Middle Aged
99
2024
13028
0.990
Why?
Adenocarcinoma
18
2018
405
0.970
Why?
Polymorphism, Single Nucleotide
10
2019
505
0.940
Why?
Fluorodeoxyglucose F18
15
2022
188
0.930
Why?
DNA-Binding Proteins
9
2021
422
0.920
Why?
MicroRNAs
7
2019
387
0.900
Why?
Neoplasm Recurrence, Local
19
2024
649
0.900
Why?
Carcinoma
12
2010
138
0.880
Why?
Oncogene Proteins, Viral
4
2019
54
0.830
Why?
Radiopharmaceuticals
14
2022
204
0.780
Why?
Cervix Uteri
7
2017
49
0.780
Why?
Repressor Proteins
4
2019
155
0.780
Why?
Alphapapillomavirus
1
2021
13
0.740
Why?
DNA, Viral
6
2019
137
0.720
Why?
Cell Line, Tumor
18
2021
1470
0.700
Why?
Immunologic Factors
2
2014
117
0.700
Why?
Neoplasm Invasiveness
15
2020
278
0.680
Why?
Neoplasms
8
2022
1325
0.660
Why?
Genetic Markers
8
2017
109
0.650
Why?
Genes, Tumor Suppressor
8
2007
74
0.650
Why?
Neoplasm Proteins
10
2019
334
0.640
Why?
Immunoglobulins
3
2017
76
0.640
Why?
Aged
70
2024
10121
0.640
Why?
Genomics
4
2018
268
0.620
Why?
Gene Silencing
5
2018
118
0.600
Why?
Biomedical Research
1
2022
256
0.600
Why?
Vascular Endothelial Growth Factor A
2
2017
182
0.540
Why?
Cisplatin
7
2022
285
0.530
Why?
Proteomics
1
2019
329
0.530
Why?
Promoter Regions, Genetic
12
2020
467
0.510
Why?
Aged, 80 and over
36
2024
3392
0.510
Why?
HLA-C Antigens
2
2018
5
0.500
Why?
Receptors, KIR
2
2018
12
0.500
Why?
Positron-Emission Tomography
11
2013
301
0.480
Why?
Ubiquitin Thiolesterase
2
2021
19
0.480
Why?
Lymph Nodes
10
2010
258
0.480
Why?
Tumor Virus Infections
4
2006
48
0.480
Why?
Microsatellite Repeats
14
2007
42
0.480
Why?
Alleles
6
2025
276
0.480
Why?
Disease-Free Survival
17
2013
460
0.470
Why?
Hysterectomy
15
2022
90
0.470
Why?
Gynecologic Surgical Procedures
4
2010
28
0.470
Why?
Virus Integration
3
2025
9
0.460
Why?
Granulosa Cell Tumor
2
2024
3
0.450
Why?
Phenotype
5
2016
789
0.440
Why?
Prognosis
19
2021
2099
0.430
Why?
Lymphatic Metastasis
14
2019
220
0.430
Why?
Chromosomes, Human, Pair 6
4
2007
15
0.430
Why?
Immunohistochemistry
13
2024
979
0.420
Why?
Nuclear Proteins
8
2009
245
0.420
Why?
Loss of Heterozygosity
10
2007
78
0.420
Why?
Ovary
2
2008
107
0.400
Why?
Membrane Proteins
3
2005
335
0.390
Why?
Genotype
9
2018
566
0.390
Why?
Survival Analysis
14
2021
673
0.380
Why?
STAT3 Transcription Factor
3
2021
85
0.380
Why?
Cell Movement
5
2021
268
0.380
Why?
Ultrasonic Therapy
3
2001
33
0.370
Why?
Peritoneal Neoplasms
4
2008
65
0.370
Why?
Carcinoma, Endometrioid
6
2014
38
0.370
Why?
Genes, p53
2
2010
52
0.370
Why?
Cell Proliferation
6
2021
1023
0.360
Why?
Signal Transduction
8
2021
1671
0.350
Why?
Risk Factors
13
2019
3889
0.350
Why?
Uterine Neoplasms
5
2009
60
0.350
Why?
Mutation
12
2018
1347
0.340
Why?
Carboplatin
2
2009
57
0.340
Why?
Ascites
2
2008
32
0.340
Why?
Antibodies, Monoclonal
5
2021
481
0.340
Why?
NAD(P)H Dehydrogenase (Quinone)
1
2010
13
0.340
Why?
Antineoplastic Agents
9
2014
1222
0.340
Why?
Proto-Oncogene Proteins c-mdm2
1
2010
13
0.340
Why?
Cohort Studies
13
2024
1542
0.330
Why?
Base Sequence
8
2019
640
0.330
Why?
Membrane Glycoproteins
2
2009
244
0.330
Why?
GTPase-Activating Proteins
1
2009
25
0.330
Why?
Disease Progression
6
2020
871
0.330
Why?
DNA, Neoplasm
11
2006
146
0.320
Why?
Chromosomes, Human, Pair 11
3
2005
55
0.320
Why?
Matrix Metalloproteinase 9
1
2009
87
0.320
Why?
Neoplasms, Glandular and Epithelial
3
2006
41
0.320
Why?
Brachytherapy
9
2014
48
0.310
Why?
Combined Modality Therapy
11
2010
639
0.310
Why?
Abdominal Neoplasms
1
2009
16
0.310
Why?
Proto-Oncogene Proteins c-myc
2
2021
53
0.310
Why?
Genome, Human
3
2025
121
0.310
Why?
DNA Repair
11
2007
195
0.310
Why?
Laser Coagulation
1
2009
27
0.310
Why?
Retrospective Studies
33
2024
6607
0.300
Why?
Drug Administration Schedule
10
2013
374
0.300
Why?
Homeodomain Proteins
2
2006
80
0.300
Why?
Deoxycytidine
4
2006
29
0.290
Why?
RNA-Binding Proteins
2
2021
128
0.290
Why?
Microsatellite Instability
5
2019
21
0.290
Why?
Protozoan Proteins
1
2008
32
0.290
Why?
Germ-Line Mutation
3
2024
66
0.290
Why?
Laparoscopy
3
2022
180
0.290
Why?
Kaplan-Meier Estimate
6
2019
483
0.290
Why?
Ovariectomy
7
2010
113
0.280
Why?
Drug Resistance, Neoplasm
6
2016
326
0.280
Why?
Antigens, CD
2
2007
218
0.280
Why?
Chromosomes, Human, Pair 3
4
2001
19
0.270
Why?
SOXC Transcription Factors
2
2019
13
0.270
Why?
Polymerase Chain Reaction
9
2010
461
0.270
Why?
Heart Arrest
1
2009
158
0.270
Why?
Receptors, Estrogen
3
2024
131
0.260
Why?
Topotecan
5
2013
17
0.260
Why?
POU Domain Factors
1
2006
1
0.260
Why?
Oligonucleotide Array Sequence Analysis
5
2010
405
0.250
Why?
Vulvar Neoplasms
5
2002
60
0.250
Why?
Neoplasm Metastasis
5
2021
243
0.250
Why?
HeLa Cells
3
2021
265
0.250
Why?
Registries
6
2010
581
0.250
Why?
Anemia
3
2020
74
0.240
Why?
Genome, Viral
2
2025
83
0.240
Why?
Survival Rate
10
2009
945
0.240
Why?
Vaginal Smears
6
2006
28
0.240
Why?
Breast Neoplasms
5
2018
1212
0.240
Why?
Young Adult
7
2018
4329
0.240
Why?
Reverse Transcriptase Polymerase Chain Reaction
4
2007
582
0.230
Why?
Gene Rearrangement
1
2025
75
0.230
Why?
Chromosome Aberrations
1
2006
297
0.230
Why?
HSP70 Heat-Shock Proteins
1
2004
61
0.220
Why?
Receptors, Androgen
1
2024
46
0.220
Why?
Receptors, Progesterone
1
2024
66
0.220
Why?
Cystadenocarcinoma, Papillary
2
2002
14
0.210
Why?
Oxidoreductases Acting on CH-NH Group Donors
1
2003
16
0.210
Why?
Oncostatin M
2
2021
5
0.210
Why?
Quinazolines
1
2003
34
0.210
Why?
Antigens, Neoplasm
1
2004
147
0.210
Why?
Polymorphism, Genetic
5
2018
185
0.210
Why?
Genome-Wide Association Study
2
2017
186
0.210
Why?
Small Cell Lung Carcinoma
1
2023
30
0.200
Why?
Omentum
1
2002
16
0.200
Why?
Case-Control Studies
7
2019
1201
0.200
Why?
Chromosome Deletion
3
2000
142
0.200
Why?
Treatment Outcome
23
2014
5422
0.200
Why?
Linkage Disequilibrium
3
2017
39
0.190
Why?
Proto-Oncogene Proteins c-akt
2
2014
169
0.190
Why?
Neoadjuvant Therapy
2
2022
125
0.190
Why?
Genetic Variation
4
2019
230
0.190
Why?
Eukaryotic Initiation Factor-4F
1
2021
1
0.190
Why?
Antibodies, Monoclonal, Humanized
5
2013
236
0.190
Why?
Tumor Microenvironment
2
2021
256
0.190
Why?
CA-125 Antigen
3
2008
16
0.190
Why?
Base Pair Mismatch
5
2006
21
0.190
Why?
Suction
1
2001
24
0.190
Why?
Chemoradiotherapy
1
2022
50
0.190
Why?
Oncostatin M Receptor beta Subunit
1
2021
1
0.190
Why?
Postoperative Complications
3
2022
1068
0.190
Why?
Smoking
1
2005
520
0.180
Why?
Radiotherapy, Conformal
2
2014
53
0.180
Why?
Proteins
5
2008
348
0.180
Why?
Carcinoma in Situ
2
2013
72
0.180
Why?
Adaptor Proteins, Signal Transducing
8
2007
202
0.180
Why?
Antimetabolites, Antineoplastic
2
2002
39
0.180
Why?
Gene Regulatory Networks
2
2019
111
0.170
Why?
Fetofetal Transfusion
1
2020
6
0.170
Why?
Polycythemia
1
2020
9
0.170
Why?
Radiotherapy
3
2010
127
0.170
Why?
Pregnancy, Twin
1
2020
8
0.170
Why?
Minority Groups
1
2022
135
0.170
Why?
Twins, Monozygotic
1
2020
16
0.170
Why?
Colorectal Neoplasms
3
2002
294
0.170
Why?
Lymph Node Excision
7
2019
133
0.170
Why?
Sarcoma
3
2009
72
0.170
Why?
Genetic Diseases, Inborn
1
2000
24
0.170
Why?
Patient Satisfaction
2
2006
284
0.170
Why?
Receptor, erbB-3
1
2020
2
0.170
Why?
Furin
1
2020
3
0.170
Why?
HLA-DQ Antigens
1
2000
3
0.170
Why?
Phosphoproteins
2
2016
119
0.170
Why?
Receptor, IGF Type 1
1
2020
22
0.170
Why?
Transcriptome
2
2020
370
0.170
Why?
Tomography, X-Ray Computed
7
2013
1165
0.160
Why?
Mice, Nude
4
2021
265
0.160
Why?
Prenatal Diagnosis
1
2020
103
0.160
Why?
Tumor Cells, Cultured
7
2021
460
0.160
Why?
RNA, Neoplasm
3
2007
45
0.160
Why?
Antibodies, Neoplasm
1
2019
28
0.160
Why?
Students
1
2022
228
0.160
Why?
Papillomavirus E7 Proteins
2
2017
32
0.160
Why?
NM23 Nucleoside Diphosphate Kinases
1
2019
4
0.160
Why?
Adolescent
13
2018
6739
0.160
Why?
Reproducibility of Results
2
2022
1229
0.160
Why?
Placenta
1
2020
153
0.150
Why?
Indocyanine Green
1
2019
33
0.150
Why?
Follow-Up Studies
13
2019
2279
0.150
Why?
Doxorubicin
4
2009
241
0.150
Why?
Fallopian Tube Neoplasms
3
2008
15
0.150
Why?
Decision Making
1
2001
282
0.150
Why?
Salvage Therapy
3
2008
136
0.150
Why?
Cyclooxygenase 2
2
2017
48
0.150
Why?
Sequence Analysis, DNA
1
2019
229
0.140
Why?
Transcription Factors
1
2021
566
0.140
Why?
HLA-DRB1 Chains
1
2017
5
0.140
Why?
HLA-B Antigens
1
2017
8
0.140
Why?
Metabolic Networks and Pathways
1
2018
93
0.140
Why?
Lung Neoplasms
2
2023
636
0.140
Why?
DNA Copy Number Variations
1
2018
117
0.140
Why?
Receptors, Vitronectin
1
1997
1
0.140
Why?
Tumor Suppressor Proteins
3
2005
130
0.140
Why?
Proto-Oncogene Proteins
5
2004
151
0.140
Why?
Carcinoma, Adenosquamous
3
2009
9
0.140
Why?
DNA Mutational Analysis
9
2005
180
0.140
Why?
Interleukin-10
1
2017
84
0.140
Why?
Bayes Theorem
1
2017
121
0.140
Why?
In Situ Hybridization
3
2008
64
0.140
Why?
Leukocytes, Mononuclear
1
2017
123
0.130
Why?
Cyclooxygenase 2 Inhibitors
1
2017
21
0.130
Why?
Protein Binding
1
2019
667
0.130
Why?
Animals
11
2021
13505
0.130
Why?
Adipose Tissue
1
2019
204
0.130
Why?
Gene Expression Regulation, Viral
1
2017
49
0.130
Why?
Radiotherapy, Intensity-Modulated
2
2009
184
0.130
Why?
Risk Assessment
9
2019
1327
0.130
Why?
Radiotherapy Dosage
8
2014
255
0.130
Why?
Body Mass Index
3
2010
689
0.130
Why?
Radiation Injuries
3
2008
110
0.130
Why?
Diagnosis, Differential
4
2024
1046
0.130
Why?
Taxoids
3
2006
37
0.130
Why?
ROC Curve
1
2017
253
0.130
Why?
Carrier Proteins
7
2006
313
0.130
Why?
Cells, Cultured
3
2017
1567
0.130
Why?
Biopsy
5
2006
605
0.130
Why?
Estrogens
1
2017
223
0.120
Why?
Prospective Studies
10
2019
2481
0.120
Why?
Colposcopy
3
2006
17
0.120
Why?
Molecular Sequence Data
5
2009
778
0.120
Why?
Mice
7
2021
5949
0.120
Why?
Wound Healing
2
2018
219
0.120
Why?
Carcinosarcoma
3
2019
18
0.120
Why?
Apoptosis
2
2021
1119
0.120
Why?
Double-Blind Method
1
2017
713
0.120
Why?
Sensitivity and Specificity
4
2006
891
0.120
Why?
Ultrasonography, Doppler, Color
1
1995
33
0.120
Why?
Aneurysm
1
1995
31
0.120
Why?
Dose-Response Relationship, Drug
6
2008
1378
0.120
Why?
Algorithms
1
2019
672
0.120
Why?
Protein Kinase Inhibitors
2
2014
227
0.120
Why?
DNA Primers
2
2006
208
0.120
Why?
Platinum Compounds
4
2008
11
0.110
Why?
Phosphatidylinositol 3-Kinases
2
2014
151
0.110
Why?
Obesity
5
2010
1162
0.110
Why?
Heterocyclic Compounds, 3-Ring
1
2014
5
0.110
Why?
Cyclohexanones
1
2014
5
0.110
Why?
Colorectal Neoplasms, Hereditary Nonpolyposis
2
2004
11
0.110
Why?
Embolization, Therapeutic
1
1995
88
0.110
Why?
Transcriptional Activation
2
2019
122
0.110
Why?
Camptothecin
3
2010
15
0.110
Why?
TOR Serine-Threonine Kinases
1
2014
80
0.110
Why?
Genetic Association Studies
1
2014
122
0.110
Why?
Introns
1
2013
53
0.110
Why?
Hypercalcemia
1
1993
34
0.110
Why?
Paclitaxel
4
2007
89
0.110
Why?
Decision Support Techniques
2
2010
70
0.100
Why?
Chromosome Mapping
3
2005
154
0.100
Why?
Pyridines
1
2014
132
0.100
Why?
Cell Transformation, Neoplastic
2
2006
184
0.100
Why?
Dermatologic Surgical Procedures
1
1992
35
0.100
Why?
Brain Neoplasms
1
2016
291
0.100
Why?
Models, Genetic
1
2012
169
0.100
Why?
Tomography, Emission-Computed
4
2005
53
0.100
Why?
Groin
2
2002
16
0.100
Why?
Keratinocytes
2
2006
93
0.100
Why?
RNA, Messenger
4
2021
1132
0.090
Why?
Glucose
1
2014
355
0.090
Why?
Cystadenocarcinoma, Serous
2
2024
73
0.090
Why?
Laser Therapy
1
1992
82
0.090
Why?
Exons
3
2007
102
0.090
Why?
Pyrazoles
2
2023
114
0.090
Why?
Infusions, Intravenous
4
2006
220
0.090
Why?
Heterozygote
2
2004
90
0.090
Why?
Condylomata Acuminata
1
1991
4
0.090
Why?
Magnetic Resonance Imaging
3
2014
1546
0.090
Why?
Models, Statistical
1
2012
230
0.090
Why?
Epithelium
2
2007
65
0.090
Why?
Goserelin
1
2010
1
0.090
Why?
Decision Trees
1
2010
22
0.090
Why?
Estrogen Antagonists
1
2010
21
0.090
Why?
Ileal Diseases
1
1990
4
0.090
Why?
Predictive Value of Tests
6
2010
944
0.090
Why?
Leiomyoma
1
1990
23
0.090
Why?
Cell Differentiation
2
2009
665
0.080
Why?
Polymorphism, Restriction Fragment Length
1
2010
66
0.080
Why?
Restriction Mapping
3
2006
33
0.080
Why?
Epigenesis, Genetic
2
2019
406
0.080
Why?
Colonic Neoplasms
2
2004
163
0.080
Why?
Gastrointestinal Hemorrhage
1
1990
89
0.080
Why?
Skin Transplantation
1
1990
44
0.080
Why?
Down-Regulation
4
2020
346
0.080
Why?
Age Factors
4
2006
1132
0.080
Why?
Maximum Tolerated Dose
5
2010
39
0.080
Why?
Fluorouracil
2
2006
59
0.080
Why?
Endometrium
3
2019
43
0.080
Why?
Urinary Bladder Diseases
1
2009
18
0.080
Why?
Intestinal Diseases
1
2009
26
0.080
Why?
Lasers, Gas
1
2009
6
0.080
Why?
Embolism, Air
1
2009
10
0.080
Why?
Transcription, Genetic
4
2019
378
0.080
Why?
Lymphatic Vessels
1
2009
55
0.080
Why?
Vaginal Neoplasms
2
2005
5
0.080
Why?
Adenocarcinoma, Clear Cell
3
2019
34
0.080
Why?
Fluorine Radioisotopes
1
2008
25
0.080
Why?
Primary Ovarian Insufficiency
1
2008
4
0.080
Why?
Infertility, Female
1
2008
19
0.080
Why?
Eimeria
1
2008
3
0.070
Why?
Haplotypes
2
2017
92
0.070
Why?
Polyethylene Glycols
2
2006
90
0.070
Why?
Up-Regulation
2
2020
454
0.070
Why?
Ubiquitin
1
2008
47
0.070
Why?
Cell Cycle Proteins
1
2009
169
0.070
Why?
Angiogenesis Inhibitors
2
2006
183
0.070
Why?
Cricetinae
1
2008
194
0.070
Why?
Tumor Burden
2
2021
136
0.070
Why?
Expressed Sequence Tags
1
2007
8
0.070
Why?
Infusion Pumps
1
1987
13
0.070
Why?
Diagnostic Imaging
1
2009
181
0.070
Why?
Fluorescent Antibody Technique
1
2007
111
0.070
Why?
Microdissection
1
2007
19
0.070
Why?
Models, Biological
2
2008
735
0.070
Why?
Precancerous Conditions
2
2005
85
0.070
Why?
MutS Homolog 2 Protein
5
2007
12
0.070
Why?
Aorta
3
2005
165
0.070
Why?
Stromal Cells
1
2007
79
0.070
Why?
Organ Specificity
2
2018
115
0.070
Why?
Lasers
1
2007
108
0.070
Why?
Codon
2
2003
43
0.070
Why?
Pelvic Floor
1
2007
52
0.070
Why?
Recombinant Proteins
1
2008
483
0.070
Why?
Neutropenia
1
2007
115
0.070
Why?
RNA, Double-Stranded
1
2006
23
0.070
Why?
Polymorphism, Single-Stranded Conformational
6
2003
19
0.070
Why?
Tissue Fixation
1
2006
36
0.070
Why?
Intestinal Perforation
2
2006
24
0.060
Why?
Pulmonary Embolism
1
1987
86
0.060
Why?
Specimen Handling
1
2006
56
0.060
Why?
Head and Neck Neoplasms
2
2016
288
0.060
Why?
Protein Kinases
1
2006
72
0.060
Why?
Chromosomes, Artificial, Yeast
3
2000
7
0.060
Why?
Endometrial Hyperplasia
2
2002
14
0.060
Why?
Abdomen
1
2006
75
0.060
Why?
Proportional Hazards Models
4
2010
443
0.060
Why?
Papillomavirus Vaccines
1
2006
70
0.060
Why?
Neovascularization, Pathologic
1
2006
153
0.060
Why?
Recurrence
4
2010
672
0.060
Why?
Probability
4
2007
172
0.060
Why?
Dibenzocycloheptenes
1
2004
1
0.060
Why?
Terminal Care
1
2005
48
0.060
Why?
Radiation-Sensitizing Agents
1
2005
52
0.060
Why?
Cell Adhesion Molecules
1
2005
86
0.060
Why?
Quinolines
1
2004
44
0.060
Why?
Male
11
2018
26761
0.060
Why?
Tumor Suppressor Protein p53
1
2006
221
0.060
Why?
Amyloid
1
2004
36
0.060
Why?
Tissue Distribution
1
2004
171
0.050
Why?
Genes, Viral
1
2003
39
0.050
Why?
Enzyme-Linked Immunosorbent Assay
1
2004
235
0.050
Why?
Lactones
1
2003
25
0.050
Why?
Abdomen, Acute
1
2003
6
0.050
Why?
Biopsy, Needle
4
2006
183
0.050
Why?
Thrombospondins
1
2003
10
0.050
Why?
Methylenetetrahydrofolate Reductase (NADPH2)
1
2003
58
0.050
Why?
Pyrimidinones
1
2023
19
0.050
Why?
RNA, Viral
2
2016
127
0.050
Why?
Obesity, Morbid
1
2004
87
0.050
Why?
Clinical Competence
1
2006
406
0.050
Why?
Fibroma
1
2003
40
0.050
Why?
Neoplasms, Second Primary
1
2004
77
0.050
Why?
Radiotherapy, Adjuvant
3
2010
63
0.050
Why?
Congenital Abnormalities
1
2004
118
0.050
Why?
Uterine Hemorrhage
1
2002
11
0.050
Why?
Age of Onset
2
2004
110
0.050
Why?
Pneumatosis Cystoides Intestinalis
1
2002
7
0.050
Why?
PTEN Phosphohydrolase
2
2019
55
0.050
Why?
DNA, Ribosomal
1
2002
26
0.050
Why?
Blood Transfusion, Autologous
1
2002
4
0.050
Why?
Chromatography, High Pressure Liquid
1
2003
339
0.050
Why?
Genital Diseases, Female
1
2002
17
0.050
Why?
Blood Donors
1
2002
21
0.050
Why?
Acridines
1
2002
4
0.050
Why?
Pregnancy
3
2020
2680
0.050
Why?
Postmenopause
1
2002
82
0.050
Why?
Medical History Taking
1
2002
47
0.050
Why?
Medical Records
1
2002
87
0.050
Why?
Complementary Therapies
1
2002
25
0.050
Why?
Family Health
1
2002
79
0.050
Why?
AU Rich Elements
1
2021
2
0.050
Why?
Peptide Chain Initiation, Translational
1
2021
15
0.050
Why?
RNA Stability
1
2021
25
0.050
Why?
Cytokine Receptor gp130
1
2021
14
0.050
Why?
3' Untranslated Regions
1
2021
55
0.050
Why?
Receptors, Transforming Growth Factor beta
1
2001
29
0.050
Why?
Lymphatic Irradiation
1
2001
1
0.050
Why?
Blotting, Northern
2
2001
106
0.050
Why?
Diet Records
1
2001
18
0.040
Why?
Prostaglandin-Endoperoxide Synthases
1
2001
25
0.040
Why?
Blotting, Southern
3
2002
42
0.040
Why?
Internship and Residency
1
2006
448
0.040
Why?
Xenograft Model Antitumor Assays
1
2021
220
0.040
Why?
Phosphoric Monoester Hydrolases
1
2000
23
0.040
Why?
Blood Vessels
1
2001
71
0.040
Why?
Equipment Design
1
2001
293
0.040
Why?
Catheterization, Central Venous
1
2001
84
0.040
Why?
Uganda
1
2020
38
0.040
Why?
Nutrition Assessment
1
2001
66
0.040
Why?
Isoenzymes
1
2001
166
0.040
Why?
Risk Management
1
2000
31
0.040
Why?
Logistic Models
2
2017
925
0.040
Why?
Physical Chromosome Mapping
1
2000
8
0.040
Why?
Quality Improvement
1
2022
226
0.040
Why?
Incidence
3
2007
1062
0.040
Why?
Dietary Fats
1
2001
130
0.040
Why?
beta Karyopherins
1
2019
4
0.040
Why?
Patient Discharge
1
2022
330
0.040
Why?
Interviews as Topic
1
2001
275
0.040
Why?
Acid Anhydride Hydrolases
1
1999
14
0.040
Why?
Cell Survival
1
2021
612
0.040
Why?
DNA Repair Enzymes
1
1999
43
0.040
Why?
Adenosine Triphosphatases
1
1999
91
0.040
Why?
Cell Nucleus
1
2019
187
0.040
Why?
Regression Analysis
3
2006
401
0.040
Why?
Cross-Sectional Studies
1
2024
1678
0.040
Why?
Coloring Agents
1
2019
69
0.040
Why?
Chromosomes, Human, Pair 10
1
1998
4
0.040
Why?
Molecular Targeted Therapy
1
2019
133
0.040
Why?
Pregnancy Outcome
1
2020
250
0.040
Why?
Gene Dosage
1
2018
78
0.040
Why?
Histone Demethylases
1
2018
19
0.040
Why?
Th1-Th2 Balance
1
2018
2
0.040
Why?
Leptin
1
2019
148
0.040
Why?
Estradiol
1
2019
214
0.040
Why?
Databases, Genetic
1
2018
83
0.040
Why?
Major Histocompatibility Complex
1
2017
13
0.040
Why?
Epithelial-Mesenchymal Transition
1
2018
57
0.040
Why?
Genotyping Techniques
1
2017
21
0.040
Why?
Chemokines
1
2017
79
0.030
Why?
Receptors, Collagen
1
1997
3
0.030
Why?
Receptors, Fibronectin
1
1997
5
0.030
Why?
Time Factors
4
2010
2968
0.030
Why?
Coculture Techniques
1
2017
144
0.030
Why?
Mass Screening
1
2000
357
0.030
Why?
Interferon-gamma
1
2018
180
0.030
Why?
Transforming Growth Factor beta
1
2018
138
0.030
Why?
Child
4
2018
7248
0.030
Why?
Integrins
1
1997
31
0.030
Why?
Chemotherapy, Adjuvant
2
2010
124
0.030
Why?
Quality-Adjusted Life Years
2
2010
66
0.030
Why?
Diet, High-Fat
1
2019
236
0.030
Why?
Epithelial Cells
2
2006
215
0.030
Why?
Hepatitis Viruses
1
2016
2
0.030
Why?
Longitudinal Studies
1
2019
747
0.030
Why?
Herpesviridae
1
2016
19
0.030
Why?
Viruses
1
2016
25
0.030
Why?
Host-Pathogen Interactions
1
2017
144
0.030
Why?
Mice, Transgenic
1
2017
552
0.030
Why?
Pilot Projects
3
2004
721
0.030
Why?
Gastrointestinal Neoplasms
1
2016
42
0.030
Why?
Cost-Benefit Analysis
2
2010
267
0.030
Why?
DNA Replication
1
1997
160
0.030
Why?
Baths
1
1995
5
0.030
Why?
Plasmids
2
2001
163
0.030
Why?
Sequence Analysis, RNA
1
2016
100
0.030
Why?
Central Nervous System Neoplasms
1
2016
68
0.030
Why?
Fibroblasts
1
2017
355
0.030
Why?
Electrosurgery
1
1995
9
0.030
Why?
Macrophages
1
2018
379
0.030
Why?
Prostatic Neoplasms
1
1998
398
0.030
Why?
DNA Probes, HPV
2
1991
3
0.030
Why?
CpG Islands
2
2008
121
0.030
Why?
Computational Biology
1
2016
212
0.030
Why?
Arteries
1
1995
92
0.030
Why?
Cytokines
1
2017
623
0.030
Why?
Class I Phosphatidylinositol 3-Kinases
1
2014
17
0.030
Why?
Multivariate Analysis
2
2009
591
0.030
Why?
Treatment Failure
2
2008
122
0.030
Why?
Dementia
1
1995
134
0.030
Why?
Missouri
2
2006
66
0.030
Why?
Inclusion Bodies
1
1993
17
0.030
Why?
Organs at Risk
1
2014
75
0.030
Why?
Parathyroid Hormone-Related Protein
1
1993
23
0.030
Why?
Cell Division
2
1994
291
0.030
Why?
Cell Death
1
2014
177
0.030
Why?
Cholera Toxin
1
1993
16
0.030
Why?
Cholera
1
1993
2
0.030
Why?
Risk
2
2004
316
0.030
Why?
Imaging, Three-Dimensional
1
2014
154
0.030
Why?
Skin Physiological Phenomena
1
1992
15
0.020
Why?
Guinea Pigs
1
1992
75
0.020
Why?
Pelvis
2
2004
69
0.020
Why?
Epidermis
1
1992
32
0.020
Why?
Pedigree
2
2004
125
0.020
Why?
Deoxyglucose
1
2012
35
0.020
Why?
Regeneration
1
1992
79
0.020
Why?
Colectomy
1
1992
35
0.020
Why?
Computer Simulation
1
2012
290
0.020
Why?
Sequence Deletion
2
2003
73
0.020
Why?
Premenopause
1
2010
27
0.020
Why?
Amino Acid Sequence
2
2003
578
0.020
Why?
Staurosporine
1
2010
13
0.020
Why?
Anastomosis, Surgical
1
1990
68
0.020
Why?
Molecular Weight
1
1990
82
0.020
Why?
Remission Induction
1
2010
218
0.020
Why?
Proto-Oncogene Proteins p21(ras)
2
2001
69
0.020
Why?
ras Proteins
2
2001
64
0.020
Why?
Cicatrix
1
1990
42
0.020
Why?
Staining and Labeling
1
1990
97
0.020
Why?
Hemoglobins
1
1990
112
0.020
Why?
Chi-Square Distribution
1
2010
288
0.020
Why?
Perioperative Care
1
2009
43
0.020
Why?
Fetus
1
1990
194
0.020
Why?
Urinary Incontinence
1
2009
40
0.020
Why?
Organoplatinum Compounds
1
2008
14
0.020
Why?
Gene Knockdown Techniques
1
2009
108
0.020
Why?
Vinblastine
1
2008
23
0.020
Why?
Life Style
1
2009
145
0.020
Why?
Dose-Response Relationship, Radiation
1
2008
184
0.020
Why?
Emotions
1
2009
174
0.020
Why?
Cadherins
1
2007
62
0.020
Why?
Demography
1
2007
90
0.020
Why?
Cell Line
1
1990
1030
0.020
Why?
Intracellular Signaling Peptides and Proteins
1
2008
134
0.020
Why?
Cytoplasmic Structures
1
2006
1
0.020
Why?
DNA Mismatch Repair
1
2006
18
0.020
Why?
Tissue Embedding
1
2006
1
0.020
Why?
Skin
1
1990
422
0.020
Why?
Eukaryotic Initiation Factor-2
1
2006
17
0.020
Why?
Waxes
1
2006
2
0.020
Why?
NIH 3T3 Cells
1
2006
51
0.020
Why?
Immunoenzyme Techniques
2
2001
137
0.020
Why?
Tomography Scanners, X-Ray Computed
1
2006
11
0.020
Why?
Chromosomal Instability
1
2006
16
0.020
Why?
Neoplasm, Residual
1
2007
173
0.020
Why?
Cryopreservation
1
2006
41
0.020
Why?
Analysis of Variance
1
2007
554
0.020
Why?
Transfection
1
2006
357
0.020
Why?
Mutation, Missense
1
2006
108
0.020
Why?
Gene Expression
1
2008
618
0.020
Why?
Nurse Practitioners
1
2006
44
0.020
Why?
Gynecology
1
2006
52
0.020
Why?
Medical Futility
1
2005
8
0.020
Why?
Ovarian Cysts
1
2005
4
0.020
Why?
Sarcoma, Endometrial Stromal
1
2005
1
0.020
Why?
Early Diagnosis
1
2006
95
0.020
Why?
Cyclophosphamide
1
2006
171
0.020
Why?
Triage
1
2006
66
0.020
Why?
Leiomyosarcoma
1
2005
21
0.020
Why?
Hospice Care
1
2005
26
0.010
Why?
Health Services
1
2005
65
0.010
Why?
Cytodiagnosis
1
2005
43
0.010
Why?
Phosphorylation
1
2006
528
0.010
Why?
Obstetrics
1
2006
89
0.010
Why?
Lymphatic System
1
2004
16
0.010
Why?
Penetrance
1
2004
7
0.010
Why?
Area Under Curve
1
2004
180
0.010
Why?
Microscopy, Electron, Transmission
1
2004
78
0.010
Why?
Calcification, Physiologic
1
2004
42
0.010
Why?
Laparotomy
1
2004
37
0.010
Why?
Bryostatins
1
2003
1
0.010
Why?
Macrolides
1
2003
17
0.010
Why?
Ethanol
1
2006
342
0.010
Why?
Genomic Instability
1
2004
89
0.010
Why?
Tamoxifen
1
2004
60
0.010
Why?
Thrombospondin 1
1
2003
7
0.010
Why?
Genes, p16
1
2003
9
0.010
Why?
Codon, Terminator
1
2003
8
0.010
Why?
Confidence Intervals
1
2003
158
0.010
Why?
Frameshift Mutation
1
2003
18
0.010
Why?
Liposomes
1
2003
54
0.010
Why?
Administration, Oral
1
2004
451
0.010
Why?
Mutagenesis, Insertional
1
2003
24
0.010
Why?
Body Weight
1
2005
523
0.010
Why?
Cytoskeletal Proteins
1
2003
48
0.010
Why?
Palliative Care
1
2005
214
0.010
Why?
Physicians
1
2006
241
0.010
Why?
DNA Transposable Elements
1
2003
107
0.010
Why?
Prevalence
1
2006
1006
0.010
Why?
Reference Values
1
2003
313
0.010
Why?
beta Catenin
1
2003
102
0.010
Why?
Retinoblastoma-Like Protein p130
1
2002
8
0.010
Why?
Retinoblastoma Protein
1
2002
19
0.010
Why?
Ifosfamide
1
2002
9
0.010
Why?
Documentation
1
2002
33
0.010
Why?
Trans-Activators
1
2003
135
0.010
Why?
Bleomycin
1
2002
38
0.010
Why?
Hospitals, University
1
2002
75
0.010
Why?
Antineoplastic Agents, Alkylating
1
2002
77
0.010
Why?
Equipment Failure
1
2001
64
0.010
Why?
Age Distribution
1
2002
174
0.010
Why?
Statistics, Nonparametric
1
2002
192
0.010
Why?
Nucleic Acid Hybridization
2
1991
56
0.010
Why?
Antibiotics, Antineoplastic
1
2002
80
0.010
Why?
Carcinoma, Small Cell
1
2001
26
0.010
Why?
Radiography
1
2002
470
0.010
Why?
Genes, erbB-1
1
2001
9
0.010
Why?
Outpatients
1
2002
125
0.010
Why?
Hospitalization
1
2005
736
0.010
Why?
Repetitive Sequences, Nucleic Acid
1
2000
90
0.010
Why?
DNA
1
2004
549
0.010
Why?
Mitogen-Activated Protein Kinases
1
2001
155
0.010
Why?
Genetic Linkage
1
2000
25
0.010
Why?
Chromosomes, Human, Pair 2
1
2000
25
0.010
Why?
Morbidity
1
2000
145
0.010
Why?
Blotting, Western
1
2001
590
0.010
Why?
Gene Deletion
1
2000
272
0.010
Why?
Carcinoma, Non-Small-Cell Lung
1
2001
170
0.010
Why?
Chromosomes, Bacterial
1
1998
5
0.010
Why?
Cloning, Molecular
1
1998
190
0.010
Why?
Infant
1
2006
3733
0.010
Why?
Child, Preschool
1
2006
4076
0.010
Why?
Drug Resistance, Multiple
1
1997
24
0.010
Why?
Antineoplastic Agents, Phytogenic
1
1997
71
0.010
Why?
Gene Frequency
1
1997
98
0.010
Why?
United States
1
2007
5192
0.010
Why?
Hygiene
1
1995
11
0.010
Why?
Guidelines as Topic
1
1995
111
0.010
Why?
Dimethyl Sulfoxide
1
1994
12
0.010
Why?
Glycerol
1
1994
19
0.010
Why?
Ambulatory Surgical Procedures
1
1995
52
0.010
Why?
Drug Screening Assays, Antitumor
1
1994
136
0.010
Why?
Drug Carriers
1
1994
73
0.010
Why?
Cell Cycle
1
1994
230
0.010
Why?
H-2 Antigens
1
1993
4
0.010
Why?
Caregivers
1
1995
240
0.010
Why?
Cell Line, Transformed
1
1993
74
0.010
Why?
Mice, Inbred Strains
1
1993
163
0.010
Why?
Retroperitoneal Space
1
1991
26
0.010
Why?
Disease Models, Animal
1
1993
1478
0.000
Why?
Rader's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description